Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epstein-Barr virus vectors for gene expression and transfer

C R Sclimenti1, M P Calos

  • 1Department of Genetics, Stanford University School of Medicine, CA 94305-5120, USA.

Current Opinion in Biotechnology
|November 20, 1998
PubMed
Summary

Epstein-Barr virus (EBV) vectors are advancing biotechnology. These vectors enhance gene expression, facilitate gene therapy, and enable the creation of large DNA-carrying vectors for genomic research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome Editing Techniques and Their Therapeutic Applications.

Clinical pharmacology and therapeutics·2016
Same author

Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy.

Gene therapy·2011
Same author

Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activity.

Gene therapy·2009
Same author

Directed evolution of a recombinase for improved genomic integration at a native human sequence.

Nucleic acids research·2002
Same author

Phage R4 integrase mediates site-specific integration in human cells.

Gene·2001
Same author

Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2001

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Virology

Background:

  • Epstein-Barr virus (EBV) components are increasingly utilized in biotechnological applications.
  • EBV-based vectors offer unique advantages for genetic manipulation and delivery.

Purpose of the Study:

  • To review recent advancements in the application of Epstein-Barr virus vectors.
  • To highlight the utility of EBV vectors in gene expression, gene therapy, and large DNA fragment delivery.

Main Methods:

  • Literature review of recent studies on EBV vector applications.
  • Analysis of EBV vector designs for gene expression systems.
  • Evaluation of EBV vector efficacy in gene therapy contexts.
  • Assessment of EBV components for constructing large DNA vectors.

Related Experiment Videos

Main Results:

  • EBV vectors have been refined to improve the convenience of gene expression systems.
  • Development of EBV vectors for effective gene transfer in gene therapy applications.
  • EBV components are successfully used to generate large vectors capable of carrying substantial genomic DNA regions.

Conclusions:

  • Epstein-Barr virus vectors represent a versatile and powerful tool in modern biotechnology.
  • Ongoing research continues to expand the applications of EBV vectors in various biological fields.
  • These vectors hold significant promise for future innovations in genetic engineering and therapeutic strategies.